Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
alder biopharmaceutical
allergan
american academy of neurology
amgen
antisense oligonucleotide
atogepant
benzodiazepines
biogen
biohaven
blackstone group
blackstone life sciences
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
columbia university
david goldstein
depression
detroit blog main
detroit top stories
drugs
eli lilly
epi4k
epilepsy
eptinezumab
erenumab
essential tremor
fda
What
drugs
neuro
2
×
new
aims
approval
arguments
backed
big
cause
ceo
class
commercialized
companies
competitors
decades
drug
epilepsy
fda
genes
genetic
links
make
marcio
medicines
meeting
migraine
mutations
oral
potential
praxis
precision
research
souza
stop
therapies
turn
won
year
Language
unset
Current search:
neuro
×
photo
×
" new york top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments